Send to

Choose Destination
See comment in PubMed Commons below
Mini Rev Med Chem. 2003 Dec;3(8):845-59.

The use of molecular descriptors in the design of gadolinium (III) chelates as MRI contrast agents.

Author information

  • 1Milano Research Centre, Bracco Imaging spa, Via E Folli 50, 20134 Milano, Italy.


Nuclear Magnetic Resonance Imaging (MRI) is a very useful tool in modern medical diagnostics, especially when gadolinium(III)-based contrast agents are administered to the patient with the aim of increasing the image contrast between normal and diseased tissues. The main purpose of this review is to show that a new generation of these contrast agents could be developed by making greater use of soft modelling techniques such as QSAR/QSPR after a suitable description of their molecular structure.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Bentham Science Publishers Ltd.
    Loading ...
    Support Center